Your browser doesn't support javascript.
loading
Long-Term Follow-Up of 90Y-Ibritumomab Tiuxetan, Fludarabine, and Total Body Irradiation-Based Nonmyeloablative Allogeneic Transplant Conditioning for Persistent High-Risk B Cell Lymphoma.
Puronen, Camille E; Cassaday, Ryan D; Stevenson, Philip A; Sandmaier, Brenda M; Flowers, Mary E; Green, Damian J; Maloney, David G; Storb, Rainer F; Press, Oliver W; Gopal, Ajay K.
Affiliation
  • Puronen CE; Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, Washington.
  • Cassaday RD; Department of Medicine, Division of Hematology, University of Washington, Seattle, Washington; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Stevenson PA; Department of Biostatistics, University of Washington, Seattle, Washington.
  • Sandmaier BM; Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, Washington; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Flowers ME; Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, Washington; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Green DJ; Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, Washington; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Maloney DG; Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, Washington; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Storb RF; Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, Washington; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Press OW; Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, Washington; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Gopal AK; Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, Washington; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington. Electronic address: agopal@u.washington.edu.
Biol Blood Marrow Transplant ; 24(11): 2211-2215, 2018 11.
Article in En | MEDLINE | ID: mdl-30454872
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Transplantation, Homologous / Vidarabine / Lymphoma, B-Cell / Whole-Body Irradiation / Hematopoietic Stem Cell Transplantation / Transplantation Conditioning / Antibodies, Monoclonal Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Biol Blood Marrow Transplant Journal subject: HEMATOLOGIA / TRANSPLANTE Year: 2018 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Transplantation, Homologous / Vidarabine / Lymphoma, B-Cell / Whole-Body Irradiation / Hematopoietic Stem Cell Transplantation / Transplantation Conditioning / Antibodies, Monoclonal Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Biol Blood Marrow Transplant Journal subject: HEMATOLOGIA / TRANSPLANTE Year: 2018 Document type: Article